This site contains promotional content intended for Healthcare Professionals in Ireland and other relevant decision makers | Not a HCP? Visit our Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Step-by-step instructions to guide you through the preparation and insertion of an IUS.

Inserter Background

The summary of product characteristics should be referred to before inserting an IUS.

Key considerations when preparing for an IUS insertion:

  • Obtain informed consent and arrange for chaperone.
  • An appropriately trained assistant should be present (to monitor & support the patient and assist in an emergency).
  • Basic risk assessment includes gathering information about previous intrauterine procedures. Patients who have had previous adverse events during insertion are more likely to have them again.
  • Pulse rate and blood pressure should be documented.
  • The need for pain relief during insertion should be discussed with the patient.
  • Routine antibiotic prophylaxis is not recommended pre-insertion. However, for women at increased risk of STIs, in whom testing has not been completed, prophylactic antibiotics are advised.

Inserting an IUS – the procedure

Insertion - Procedure

The summary of product characteristics should be referred to during insertion of an IUS.

  • For women with symptomatic pelvic infection, postpone insertion and treat infection. Treatment should be complete before another attempt at insertion.
  • A pelvic examination should be performed prior to inserting the device, to assess the size, shape, position and mobility of the uterus.
  • Assessment of uterine size by sound measure.
  • Forceps (tenaculum) are used to stabilise the cervix during insertion and reduce risk of perforation.
  • Some inserters offer para-cervical block for the procedure.
  • Many inserters use local anaesthetic gel on the cervix.
  • Documentation should be made in the case notes of pre- and post-insertion counselling, the procedure, the type of device inserted, and any adverse events.

Practical aspects of inserting an IUS



Step 1 - Inserting an IUS

Step 1

First, open the sterile package completely. Then use sterile technique and sterile gloves.

Potential problems at the time of insertion:

    • Stop the procedure, lower the head and/or raise the legs. The IUS may need to be removed. An assistant should monitor observations. Ensure a clear airway. ‘ABC approach’ in basic resuscitation.
    • Oxygen and suction as required. Consider use of atropine IV/IM for persistent bradycardia. Consider use of adrenalineIM 1:1000 for management of anaphylaxis.
    • Automated external defibrillator (AED) should be available. Arrange ambulance transfer if there is no improvement.
    • Syncope may be experienced at insertion secondary to vagal stimulation from the cervix. Bradycardia is more common in nulliparous women.
    • If perforation is suspected at the time of insertion, stop the procedure and monitor observations. Ultrasound or plain abdominal film to locate the device should be arranged as soon as possible, depending on device.

Post-insertion advice:

Provide patients with a patient information leaflet and advice post-insertion of IUS is an important component of patient care.

 

Key advice to be offered includes:

Cramp icon

Expect mild cramping. This usually resolves itself but if you have any concerns please contact your healthcare professional.

IUD Icon

Informing the patient on how to feel the threads (e.g. before the next episode of sexual intercourse and after her next menses) and advise her to seek medical advice if she is unable to feel them.

It may also be worthwhile discussing:

Bleeding

Bleeding

Infection Icon

Infection

Well Icon

If the patient is feeling well enough to leave and is comfortable

Document Icon

Ensure documentation completed

Appointment icon

A follow-up appointment with the patient for 6 weeks’ time

Good practice points for documentation

Detailed documentation is a key component of good practice in IUS insertion. Important points to document include:

    Medical history and clinical assessment

    Blood pressure examinations and investigations

    Information, advice and counselling:

    • Contraceptive choices discussed/preparation chosen
    • Risks/benefits/uncertainties discussed
    • How it works and efficacy
    • Potential side effects
    • Choice of device and duration of use
    • Effects on bleeding pattern
    • Risk of spontaneous expulsion and perforation and advisability of thread check and teaching
    • Risk of post-insertion pelvic infection and record of any swabs taken, if applicable
    • Bleeding pattern
    • Explanation of insertion and removal procedure
    • Consent obtained
    • Leaflets given including manufacturer’s PIL
    • Advice given on practising safe sex

    Details of insertion procedure:

    • Name of clinician/assistant
    • Any tests undertaken
    • Bimanual/speculum examination findings
    • Analgesia/local anaesthesia if used, including batch number and expiry date
    • Tenaculum/Allis application used
    • Uterine sounding/utero-cervical length
    • Type of device inserted including batch number and expiry date
    • Use of no-touch technique
    • Problems encountered, if any, and action taken

    Post-insertion advice and follow-up advice given:

    • Other treatment, if any e.g. antibiotics
    • Special instructions, if any e.g. additional contraception for 7 days
    • Follow up date if arranged; “see if any problems” acceptable

Step-by-step video guidance for the preparation, insertion, removal and replacement of the Mirena® IUS

Prescribing information of Mirena® (52 mg levonorgestrel)

Patient Materials Resources
Patient Materials
Useful, downloadable resources.
PP-PF-WHC-IE-0944-1, February 2026
arrow_forward
Mirena Product Content Card
Mirena® (52mg levonorgestrel) Intrauterine System
Learn more about Mirena®.
PP-MIR-IE-0069-1, January 2026
arrow_forward
Kyleena Content Card
Kyleena® (19.5mg Levonorgestrel)
Discover information about Kyleena's intended usage.
PP-KYL-IE-0252-1, January 2026
arrow_forward

PP-PF-WHC-IE-0935-1   |   February 2026


    • 1
      Johnson BA. Insertion and removal of intrauterine devices, American Family Physician. January (2005).
    • 2
      FSRH. Intrauterine Contraception [online] October 2015. Available from: https://www.fsrh.org/standards-and-guidance/documents/ceuguidanceintrauterinecontraception/.
    • 3
      Mirena® (52 mg intrauterine delivery system levonorgestrel): Summary of Product Characteristics.
    • 4
      Mirena® Product Monograph
    • 5
      Farmer M, Webb A; Intrauterine device insertion-related complications: can they be predicted? J Fam Plann Reprod Health Care. 2003 Oct;29(4):227-31.
    • 6
      Faculty of Sexual and Reproductive Healthcare. Service Standards for Record Keeping in Sexual and Reproductive Healthcare Services, July 2019. Available at: https://www.fsrh.org/standards-and-guidance/documents/fsrh-service-standards-for-record-keeping-july-2019/.